Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    Portage Biotech to Participate in Panel Discussion at the Cantor Global Healthcare Conference

    September 21, 2023

    Liftoff for the Biotech Launch Pad

    September 20, 2023

    Five things: A biotech IPO, Shannon O’Brien suspension, life sciences philanthropy report

    September 19, 2023
    Facebook Twitter Instagram
    Your Biotech
    • Bio Technology

      Portage Biotech to Participate in Panel Discussion at the Cantor Global Healthcare Conference

      September 21, 2023

      Liftoff for the Biotech Launch Pad

      September 20, 2023

      Five things: A biotech IPO, Shannon O’Brien suspension, life sciences philanthropy report

      September 19, 2023

      Machine learning biotech raises $273 million in rare successful late-stage round

      September 15, 2023

      Discover the synergy between biotech, medtech and digital health in Ghent, a European technology capital

      September 14, 2023
    • Pharmaceutical

      Pharma company owner duped of ₹1.1 crore

      November 11, 2022

      Novavax cuts full-year revenue forecast again amid weak demand

      November 10, 2022

      Aurobindo units recall products in US market for manufacturing issues

      November 9, 2022

      AASLD 2022 | Ascentage Pharma Releases Phase I Results of IAP Antagonist APG-1387 in an Oral Report Showing Potential for Functionally Curing CHB

      November 8, 2022

      Trade Spotlight | What should you do with Amara Raja, Sun Pharma Advanced Research, Poly Medicure on Monday?

      November 7, 2022
    Your Biotech
    Home»Bio Technology»U.S. criticizes China’s zero Covid strategy, says Beijing needs to boost vaccination among elderly
    Bio Technology

    U.S. criticizes China’s zero Covid strategy, says Beijing needs to boost vaccination among elderly

    yourbiotechBy yourbiotechNovember 30, 2022No Comments3 Mins Read
    Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp VKontakte Email
    Share
    Facebook Twitter LinkedIn Pinterest Email

    The White House on Monday criticized Beijing’s zero Covid strategy as ineffective and said the Chinese people have a right to peacefully protest.

    “We’ve long said everyone has the right to peacefully protest, here in the United States and around the world. This includes in the PRC,” a spokesperson for President Joe Biden’s National Security Council said in a statement.

    Rare protests broke out against Covid lockdowns in Beijing, Shanghai, Urumqi and other cities over the weekend. Nearly three years after the virus first emerged in Wuhan, China is still imposing strict social controls to quash Covid outbreaks, while countries such as the U.S. have largely returned to normal life.

    “We’ve said that zero COVID is not a policy we pursuing here in the United States,” the NSC spokesperson said. “And as we’ve said, we think it’s going to be very difficult for the People’s Republic of China to be able to contain this virus through their zero COVID strategy.”

    The U.S. Covid response is focused on increasing vaccination rates and making testing and treatment more accessible, the spokesperson said

    China’s stringent Covid controls have kept deaths very low compared to the U.S., but the measures have also deeply disrupted economic and social life. In China, more than 30,000 people have died from Covid since the pandemic began, according to the World Health Organization. In the U.S., more than 1 million people have died.

    Dr. Anthony Fauci, the top infectious disease expert in the U.S., said China’s approach to Covid “doesn’t make public health sense.” Vaccination rates among the elderly, one of the groups most vulnerable to Covid, are low in China compared to other countries. The vaccination campaign in China focused on people in critical positions first, those ages 18 to 59 next, and only then people ages 60 and over.

    “If you look at the prevalence of vaccinations among the elderly, that it was almost counterproductive, the people you really needed to protect were not getting protected,” Fauci told NBC’s Meet the Press on Sunday. A temporary lockdown might make sense if the goal was to buy time to boost vaccination rates but China doesn’t seem to be doing that, he said.

    “It seems that in China, it was just a very, very strict extraordinary lockdown where you lock people in the house but without any seemingly endgame to it,” Fauci said.


    Why China shows no sign of backing away from its ‘zero-Covid’ strategy
    As of August, about 86% of people ages 60 and older in China were fully vaccinated and 68% had received a booster, according to a September report from China’s Center for Disease Control and Prevention. By comparison, 92% of older Americans were fully vaccinated and 70% had received a booster during that same period.

    Fauci said China’s domestically developed vaccines are also not very effective.

    The authors of the China CDC report said older people are more skeptical of the vaccine. The clinical trials didn’t enroll enough older people and as a consequence there wasn’t sufficient data on the vaccine’s safety and efficacy for this age group when the immunization campaign started, they wrote.

    Dr. Ashish Jha, head of the White House Covid task force, said China should focus on making sure the elderly get vaccinated.

    “That I think is the path out of this virus. Lockdowns and zero COVID is going to be very difficult to sustain,” Jha told ABC’s “This Week” on Sunday.

    Share. Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp Email
    Previous ArticleWorld’s first intranasal Covid vaccine from Bharat Biotech gets CDSCO approval
    Next Article CDC will test sewage for polio outside New York to see if it’s circulating elsewhere in nation
    yourbiotech
    • Website

    Related Posts

    Portage Biotech to Participate in Panel Discussion at the Cantor Global Healthcare Conference

    September 21, 2023

    Liftoff for the Biotech Launch Pad

    September 20, 2023

    Five things: A biotech IPO, Shannon O’Brien suspension, life sciences philanthropy report

    September 19, 2023

    Machine learning biotech raises $273 million in rare successful late-stage round

    September 15, 2023

    Leave A Reply Cancel Reply

    Our Picks

    Subscribe to Updates

    Get the latest creative news from SmartMag about art & design.

    About Us
    About Us

    We provide a wide range of customized, integrated B2B and B2C digital marketing services solutions that are ideal for your business.

    We're accepting new partnerships right now.

    Email Us: info@yourmartech.com
    Contact: +1-530-518-1420

    Our Brands
    • Your Martech
    • Your HR Tech
    • Your Fin Tech
    • Your Revenue
    • Your Info Tech
    • Your POS Tech
    • Your Health Tech
    SUBSCRIBE NOW
    Loading
    LinkedIn
    • Privacy Policy
    © 2022 Vigarbiz Inc. Designed by Vigarbiz Media

    Type above and press Enter to search. Press Esc to cancel.